These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7050419

  • 21. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
    Lanzafame S, Puzzo L, Di Naso C, Di Marco G, Ranno S, Minardi G.
    Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
    [No Abstract] [Full Text] [Related]

  • 22. [Biologic significance and clinical value of carcinoembryonic antigen in tissues in transitional cell carcinoma of the urinary tract].
    Yang SC.
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):228-30, 254. PubMed ID: 2805992
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Heterogeneic expression of blood group A and H isoantigens in bladder tumors: association with nuclear volume.
    Orntoft TF, Nielsen K.
    J Histochem Cytochem; 1989 Jul; 37(7):1153-5. PubMed ID: 2732458
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Changing expression of ABH blood group and cryptic T-antigens of noninvasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression.
    Yamada T, Fukui I, Yokokawa M, Oshima H.
    Cancer; 1988 Feb 15; 61(4):721-6. PubMed ID: 3338034
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Visualization of urothelial blood group isoantigens A and B using direct biotin-labeled antibodies and avidin-biotin-peroxidase complex.
    Lin CW, Fujime M, Kirley SD, Prout GR.
    J Histochem Cytochem; 1984 Dec 15; 32(12):1139-43. PubMed ID: 6209329
    [Abstract] [Full Text] [Related]

  • 32. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
    Kumon H, Nasu Y, Matsumura Y, Ohmori H.
    Nihon Hinyokika Gakkai Zasshi; 1984 May 15; 75(5):731-8. PubMed ID: 6492527
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G, Cavallini A, Piana P, Squintone L, Vottero M, Tizzani A.
    Minerva Urol Nefrol; 1992 May 15; 44(3):169-72. PubMed ID: 1492266
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of specific red-cell adherence and immunoperoxidase staining techniques for ABO(H) blood-group cell-surface antigens on superficial transitional cell carcinoma of the bladder.
    Boileau MA, Cowles RS, Schmidt KL, Schmidt WA.
    J Surg Oncol; 1985 Oct 15; 30(2):72-9. PubMed ID: 3908825
    [Abstract] [Full Text] [Related]

  • 40. Blood group precursor T-antigen expression in human urinary bladder carcinoma.
    Coon JS, Weinstein RS, Summers JL.
    Am J Clin Pathol; 1982 Jun 15; 77(6):692-9. PubMed ID: 7091049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.